What Patient Factors Influence the Success of Embolization in cSDH Management?
Middle Meningeal Artery Embolization is a minimally invasive procedure used to treat chronic subdural hematoma (cSDH) by blocking the blood supply to the hematoma membrane. By injecting embolic agents into the middle meningeal artery (MMA), this technique reduces inflammation and prevents further hematoma expansion, promoting natural resorption.
The beneficial effects of treatment and long-term results are impacted by several patient-specific factors that affect the management of chronic subdural hematoma embolization. Because elderly patients with several comorbidities may recover more slowly and have reduced vascular integrity, age and overall health are key factors in hematoma approval. The degree to which embolization is successful also depends on the size and chronicity of the hematoma; smaller, less structured hematomas are more amenable to embolization than bigger, more septated, or longer-standing ones.
The healing process may be impacted by underlying neurological conditions such as Parkinson's or Alzheimer's disease, and severe brain shrinkage, which is common in the elderly, may compromise the integrity of the subdural space and raise the risk of recurrent bleeding.
What's Your Reaction?
